Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Open accessThe DOI matches its Crossref record; 621 of the 628 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is now recognized as an important metabolic as well as reproductive disorder conferring substantially increased risk for type 2 diabetes. Affected women have marked insulin resistance, independent of obesity. This article summarizes the state of the science since we last reviewed the field in the Endocrine Reviews in 1997. There is general agreement that obese women with PCOS are insulin resistant, but some groups of lean affected women may have normal insulin sensitivity. There is a post-binding defect in receptor signaling likely due to increased receptor and insulin receptor substrate-1 serine phosphorylation that selectively affects metabolic but not mitogenic pathways in classic insulin target tissues and in the ovary. Constitutive activation of serine kinases in the MAPK-ERK pathway may contribute to resistance to insulin's metabolic actions in skeletal muscle. Insulin functions as a co-gonadotropin through its cognate receptor to modulate ovarian steroidogenesis. Genetic disruption of insulin signaling in the brain has indicated that this pathway is important for ovulation and body weight regulation. These insights have been directly translated into a novel therapy for PCOS with insulin-sensitizing drugs. Furthermore, androgens contribute to insulin resistance in PCOS. PCOS may also have developmental origins due to androgen exposure at critical periods or to intrauterine growth restriction. PCOS is a complex genetic disease, and first-degree relatives have reproductive and metabolic phenotypes. Several PCOS genetic susceptibility loci have been mapped and replicated. Some of the same susceptibility genes contribute to disease risk in Chinese and European PCOS populations, suggesting that PCOS is an ancient trait.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Insulin resistance and hyperinsulinemia, either directly or indirectly, through factors such as adiposity can lead to increase circulating androgen levels (6).”
From Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis (2025) · cites this paper as [6]
In the citing paper
“Androgen excess favors visceral fat deposition and lipid dysfunction with a vicious cycle of worsening of hyperinsulinemia and insulin resistance (6).”
From Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis (2024) · cites this paper as [6]
In the citing paper
“primarily due to hyperinsulinemia resulting from insulin resistance, which increases ovarian androgen production [162, 163].”
From Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan (2025) · cites this paper as [163]
In the citing paper
“Moreover, women who have both obesity and PCOS exhibit a greater level of insulin resistance in comparison to obese persons who do not have PCOS [53].”
In the citing paper
“Consensus is yet to be achieved in lean women with PCOS as IR is not consistently demonstrated (Diamanti-Kandarakis and Dunaif, 2012).”
From Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies (2016) · cites this paper as Diamanti-Kandarakis and Dunaif, 2012
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Items 601–621 of 621
Zaidi, F. K., Wareham, N. J., McCarthy, M. I., Holdstock, J., Kalloo-Hosein, H., Krook, A., Swinn, R. A., & O’ Rahilly, S. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199703)14:3<228::aid-dia330>3.0.co;2-n · Cited by 26
Vicini, P., Sparacino, G., Caumo, A., & Cobelli, C. (1997) · Computer Methods and Programs in Biomedicine · doi:10.1016/s0169-2607(96)01784-1 · Cited by 25
Yalamanchi, S. K., Sam, S., Cardenas, M. O., Holaday, L. W., Urbanek, M., & Dunaif, A. E. (2012) · Obesity · doi:10.1038/oby.2011.400 · Cited by 25
Self-citationTissue-specificity of insulin action and resistance*
Benito, M. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.563748 · Cited by 23
Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome
(2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.004 · Cited by 23
Arlt, W., Neogi, P., Gross, C., & Miller, W. L. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0320425 · Cited by 22
Insulin Signal Transduction by a Mutant Human Insulin Receptor Lacking the NPEY Sequence
Berhanu, P., Anderson, C. M., Hickman, M., & Ciaraldi, T. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22884 · Cited by 21
Involvement of ALF in human spermatogenesis and male infertility
Huang, M., Wang, H., Li, J., Zuomin, Z., Du, Y., Lin, M., & Sha, J. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.4.599 · Cited by 21
Bennett, A. J., Sovio, U., Ruokonen, A., Martikainen, H. K., Pouta, A. M., Taponen, S., Hartikainen, A. L., Franks, P. W., Peltonen, L., Elliott, P., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1737-z · Cited by 20
Martens, J. W. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.11.4338 · Cited by 19
Park, H. R., Choi, Y., Lee, H., Oh, J. Y., Hong, Y. S., & Sung, Y. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.063 · Cited by 18
Ogawa, K., Ono, K., Kurohmaru, M., & Hayashi, Y. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320363 · Cited by 15
Acute insulin response to intravenous glucagon in polycystic ovary syndrome
Ciampelli, M., Fulghesu, A. M., Murgia, F., Guido, M., Cucinelli, F., Apa, R., Caruso, A., & Lanzone, A. (1998) · Human Reproduction · doi:10.1093/humrep/13.4.847 · Cited by 14
Barber, T. M., Golding, S. J., Alvey, C., Wass, J. A. H., Karpe, F., Franks, P. W., & McCarthy, M. I. (2008) · Society for Endocrinology BES 2008 · Cited by 10
Fasting Insulin Pulsatile Secretion in Lean Women with Polycystic Ovary Syndrome
Grimmichová, T., Vrbíková, J., Matucha, P., Vondra, K., Veldhuis, P. P., & Johnson, M. (2008) · Physiological Research · doi:10.33549/physiolres.931493 · Cited by 9
Genetic mapping of complex characters
Strachan, T., & Read, A. (1999) · Cited by 8
Goldzieher, J. W. (2002) · CRC Press eBooks · doi:10.3109/9780203910948-4 · Cited by 6
Portnoy, B., Miller, J. E., Brown-Huamani, K., & DeVoto, E. (2007) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462307070511 · Cited by 5
Fasting Glucose to Insulin Ratio, or Product of Glucose and Insulin?—Authors’ Response
Legro, R. S., & Dunaif, A. E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5427-4 · Cited by 4
Self-citationGoldzieher, J. W. (2002) · Informa Healthcare eBooks · doi:10.1201/9780203910948.pt1 · Cited by 4
(1947) · PubMed
Research works printed but not linked: 5
- Achard, 1921, Le virilisme et son association à l'insuffisance glycolytique (diabète des femmes à barbe), Bull Acad Natl Med (Paris), 86, 51
- Vague, 1947, La différentiation sexuelle. Facteur determinant des formes de l'obesité, Presse Med, 55, 339
- Chereau, 1844, Mémoires pour servir à l'étude des malades ovaires
- Givens, 1992, Historical Overview of the Polycystic Ovary, 3
- Zawadzki, 1992, Diagnostic criteria for polycystic ovary syndrome; towards a rational approach, 377
Cited by
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Self-citationRosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358
Epidemiology, diagnosis, and management of polycystic ovary syndrome
Sirmans, S., & Pate, K. (2013) · Clinical Epidemiology · doi:10.2147/clep.s37559 · Cited by 1,302
Metadata
- Authors
- Diamanti-Kandarakis, E., & Dunaif, A.
- Affiliations
- Medical School, University of Athens (E.D.-K.), Athens GR-14578, Greece
- Northwestern University (US)
- ORCID
- Dunaif, Andrea
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2012-10-12
- Volume
- 33
- Issue
- 6
- Pages
- 981-1030
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC5393155
- OpenAlex
- W1967263394
- Semantic Scholar
- b2b7fa060bf61f261edf17bef51cbbbd222742e0
- Cited by
- 1,947
- References
- 628
- Citations by year
- 2026: 183 · 2025: 178 · 2024: 182 · 2023: 221 · 2022: 191 · 2021: 184 · 2020: 136 · 2019: 140 · 2018: 108 · 2017: 97 · 2016: 96 · 2015: 92 · 2014: 91 · 2013: 43 · 2012: 4
- FWCI
- 9.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK073411)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD044405, R01HD057223, U54HD034449)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, insulin resistance, insulin receptor signaling, MAPK/ERK pathway, skeletal muscle insulin sensitivity, ovarian steroidogenesis, ovulation, brain insulin signaling, body weight regulation, insulin-sensitizing drugs, androgens, developmental origins of health and disease, fetal growth restriction, genetic susceptibility loci, type 2 diabetes risk, lean PCOS
- MeSH terms
- Female, Humans, Insulin Resistance, Phenotype, Polycystic Ovary Syndrome, Reproduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.